Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BioCardia, Inc. Director's Dealing 2013

Jan 2, 2013

35081_dirs_2013-01-02_8d6eab36-851d-4fed-a110-6f2127b5d8e3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Tiger X Medical, Inc. (CDOM)
CIK: 0000925741
Period of Report: 2012-12-26

Reporting Person: Brooks Andrew A (Director, CEO, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-12-26 Common Stock P 49000 $0.06 Acquired 61873189 Direct
2012-12-28 Common Stock P 6000 $0.058 Acquired 61879189 Direct
2012-12-31 Common Stock P 674205 $0.0649 Acquired 62553394 Direct